Category Archives: Biotechnology

Life Isn’t as Sweet as it May Seem in Biotech’s C-Suites

Biotechnology is an idiosyncratic industry in which some executives can stake their careers on the pursuit of orphan drugs that, at best, will offer only limited opportunity for corporate profits and investors returns, while addressing the usually unmet needs of…

Share

Where’s Rube Goldberg When You Need Him?

What’s the difference between Congress and a Rube Goldberg contraption? They both use convoluted processes to accomplish a simple task, but the Goldberg invention still manages to keep the end result pretty simple. And while there may be some unintended…

Share

Is it Better to Forgive and Pharm-merge?

Aug. 5 was International Forgiveness Day, and the founding organization of this annual effort, Worldwide Forgiveness Alliance (WFA), says in its mission statement that a goal is to promote and publicize the research findings that show forgiveness creates better health,…

Share

The Pharm-eleon is Shedding its Pharma-saurus Skin Again

If the big pharmas are indeed dinosaurs, they have learned to do what their predecessors could not: survive! Pharma may be prehistoric in terms of age compared to biotech, but it maneuvers more like a velociraptor than lumbering brontosaurus, as…

Share

Venter, Watson Warm Up for Clash of the Titans

DUBLIN ‑ Europe’s biggest scientific carnival is pitching its tent beside the River Liffey this week. Dublin is playing host to the Euroscience Open Forum (ESOF) 2012 meeting and, thereby, assumes the mantle of Europe’s City of Science for the…

Share

BioWorld’s Biotech Summer Reading List Plumbs the Classics, BioEthics & Life’s Simple Pleasures

With the 2012 BIO International Convention behind us and the Fourth of July signaling summer vacation season in earnest, thoughts turn to visions of sun, sand and afternoons lounging in a deck chair. Again this year, BioWorld polled biotech execs,…

Share

BIO-Buzzwords Won’t Die, So We May as Well Evolve Them

For BIO 2011, BioWorld published a list of overused BioCliches to shun, and I was pleased to observe that attendees and speakers must’ve taken notice and avoided using them at BIO 2012 this year. However, since the urge to use…

Share

Michael’s Personal BIO 2012 Wrap-Up

Day One: The wait is over! I leap off the bus and race the other lively stepping attendees to the registration corridor, exchanging pleasantries with everyone I pass. My first-day euphoria high carries me though five sessions, over three miles…

Share

A Stifled U.S. Biotech Sector: Is it Too Late to Recover?

BOSTON ‑ Amid all of the excitement that comes with the biopharma industry’s largest annual gathering in Boston this week, I’m worried about the future. The U.S. has lost too much ground ‑ due to the obvious partisan gridlock in…

Share

#BIO2012: Tips for a Wicked Good Meeting

Heading to Boston next week for the 2012 Biotechnology Industry Organization International convention? So are we. In fact, BioWorld has attended and exhibited at the annual BIO meeting for 18 years, so we know a thing or two about navigating…

Share